nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—NISCH—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.228	0.256	CbGpPWpGaD
Naphazoline—Duloxetine—SLC6A4—conduct disorder	0.0621	0.565	CrCbGaD
Naphazoline—Duloxetine—HTR2A—conduct disorder	0.0477	0.435	CrCbGaD
Naphazoline—ADRA2B—Monoamine GPCRs—DRD4—conduct disorder	0.0351	0.0395	CbGpPWpGaD
Naphazoline—ADRA2C—Monoamine GPCRs—DRD4—conduct disorder	0.0328	0.0369	CbGpPWpGaD
Naphazoline—ADRA2B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0295	0.0332	CbGpPWpGaD
Naphazoline—ADRA1A—Monoamine GPCRs—DRD4—conduct disorder	0.0287	0.0322	CbGpPWpGaD
Naphazoline—ADRA2C—Amine ligand-binding receptors—DRD4—conduct disorder	0.0276	0.031	CbGpPWpGaD
Naphazoline—ADRA2A—Monoamine GPCRs—DRD4—conduct disorder	0.0267	0.03	CbGpPWpGaD
Naphazoline—ADRA1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.0241	0.0271	CbGpPWpGaD
Naphazoline—ADRA2B—Monoamine GPCRs—HTR2A—conduct disorder	0.0229	0.0258	CbGpPWpGaD
Naphazoline—ADRA2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.0224	0.0252	CbGpPWpGaD
Naphazoline—ADRA2C—Monoamine GPCRs—HTR2A—conduct disorder	0.0214	0.0241	CbGpPWpGaD
Naphazoline—ADRA2B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0193	0.0217	CbGpPWpGaD
Naphazoline—ADRA1A—Monoamine GPCRs—HTR2A—conduct disorder	0.0187	0.021	CbGpPWpGaD
Naphazoline—ADRA2C—Amine ligand-binding receptors—HTR2A—conduct disorder	0.018	0.0202	CbGpPWpGaD
Naphazoline—ADRA2A—Monoamine GPCRs—HTR2A—conduct disorder	0.0174	0.0195	CbGpPWpGaD
Naphazoline—ADRA1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0157	0.0177	CbGpPWpGaD
Naphazoline—ADRA2A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0146	0.0164	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0104	0.0117	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00969	0.0109	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00847	0.00952	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—CGA—conduct disorder	0.0079	0.00888	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00787	0.00884	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—CGA—conduct disorder	0.00738	0.00829	CbGpPWpGaD
Naphazoline—ADRA2B—G alpha (i) signalling events—DRD4—conduct disorder	0.00731	0.00821	CbGpPWpGaD
Naphazoline—ADRA2C—G alpha (i) signalling events—DRD4—conduct disorder	0.00683	0.00767	CbGpPWpGaD
Naphazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00678	0.00762	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.00645	0.00725	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00633	0.00712	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.00599	0.00673	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00581	0.00653	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.00554	0.00623	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00554	0.00622	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00543	0.0061	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00515	0.00578	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00474	0.00533	CbGpPWpGaD
Naphazoline—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.00467	0.00525	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.00446	0.00502	CbGpPWpGaD
Naphazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00442	0.00497	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.00442	0.00497	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00441	0.00495	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00418	0.0047	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	0.00417	0.00469	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00413	0.00464	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	0.00413	0.00464	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.00405	0.00455	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00379	0.00426	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CGA—conduct disorder	0.00379	0.00425	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.00365	0.0041	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00361	0.00406	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.00361	0.00406	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00354	0.00398	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	0.00339	0.00381	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00336	0.00377	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	0.00336	0.00377	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.00331	0.00372	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0031	0.00348	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CGA—conduct disorder	0.00308	0.00346	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	0.00289	0.00324	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00288	0.00323	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	0.0027	0.00303	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CGA—conduct disorder	0.00268	0.00301	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	0.0025	0.00281	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CGA—conduct disorder	0.0024	0.00269	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.00236	0.00265	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	0.00234	0.00262	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	0.00227	0.00255	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CGA—conduct disorder	0.00224	0.00251	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	0.00219	0.00246	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CGA—conduct disorder	0.00217	0.00244	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	0.00212	0.00238	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	0.00204	0.00229	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CGA—conduct disorder	0.00196	0.0022	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—WASF1—conduct disorder	0.00192	0.00216	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	0.0019	0.00213	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	0.00185	0.00208	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CGA—conduct disorder	0.00182	0.00204	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—WASF1—conduct disorder	0.00179	0.00201	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	0.00172	0.00194	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	0.00163	0.00183	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—WASF1—conduct disorder	0.00157	0.00176	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	0.00152	0.00171	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	0.00148	0.00166	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—WASF1—conduct disorder	0.00146	0.00164	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	0.00138	0.00155	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—EP300—conduct disorder	0.00137	0.00154	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—DRD4—conduct disorder	0.00134	0.00151	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	0.00133	0.0015	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—EP300—conduct disorder	0.00128	0.00144	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—DRD4—conduct disorder	0.00125	0.00141	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	0.00124	0.00139	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	0.00121	0.00136	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—COMT—conduct disorder	0.00121	0.00136	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—MAOA—conduct disorder	0.0012	0.00135	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	0.00112	0.00126	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—DRD4—conduct disorder	0.0011	0.00123	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—EP300—conduct disorder	0.00104	0.00117	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—DRD4—conduct disorder	0.00102	0.00114	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—COMT—conduct disorder	0.000981	0.0011	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—MAOA—conduct disorder	0.000974	0.00109	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	0.000875	0.000983	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	0.000817	0.000918	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	0.000715	0.000803	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	0.000664	0.000746	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—EP300—conduct disorder	0.000518	0.000582	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EP300—conduct disorder	0.000464	0.000521	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EP300—conduct disorder	0.000433	0.000487	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—EP300—conduct disorder	0.000421	0.000473	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EP300—conduct disorder	0.000379	0.000425	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EP300—conduct disorder	0.000352	0.000395	CbGpPWpGaD
